No definition available.
Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)
C3_SMALL_INTESTINE_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1056 |
4. Check minimum number of eventsNone |
1056 |
5. Include endpointsNone |
1056 |
6. Filter based on genotype QC (FinnGen only) |
1056 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
- Malignant neoplasm of small intestine
- Neuroendocrine tumor and carcinoma of small intestine
- Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)
- Adenocarcinoma of small intestine
- Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1056 | 488 | 568 |
| Unadjusted period prevalence (%) | 0.21 | 0.17 | 0.25 |
| Median age at first event (years) | 64.15 | 61.99 | 66.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 676
- Matched controls
- 6759
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
348
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
323.0
298
*
JFB00
NOMESCO Finland
Partial resection of small intestine
242.9
318.4
307
23
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
360.9
229.8
220
9
JN4BD
NOMESCO Finland
Extensive body CT
30.4
188.1
260
136
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
175.9
161
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
46.7
159.2
195
58
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
+∞
149.6
138
*
H01CB03
ATC
lanreotide; parenteral
+∞
144.0
133
*
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
131.6
122
*
H01CB02
ATC
octreotide; parenteral
1497.8
130.7
123
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
122.7
114
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
11.7
117.2
240
303
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
+∞
114.9
107
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.8
112.9
261
409
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
111.6
104
*
JN4AD
NOMESCO Finland
Body CT examination
21.8
111.1
168
101
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
95.1
89
*
A04AA02
ATC
granisetron; systemic, transdermal
474.6
86.1
84
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
24.2
85.8
124
62
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
14.0
84.5
152
137
L01BC06
ATC
capecitabine; oral
+∞
80.9
76
*
H02AB02
ATC
dexamethasone; systemic
34.5
78.9
103
35
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
20.4
73.4
112
65
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
29.5
72.9
99
39
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
+∞
71.1
67
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
71.1
67
*
B01AB05
ATC
enoxaparin; parenteral
4.6
70.2
344
1252
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
+∞
70.0
66
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.5
68.9
345
1277
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
68.9
65
*
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
+∞
67.9
64
*
JN4CD
NOMESCO Finland
Very extensive body CT
25.5
65.7
93
42
Z51.5
ICD-10 Finland
Palliative care
22.2
64.9
96
50
D77
ICPC
Malignant digestive neopl other/NOS
+∞
63.5
60
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
4.1
63.0
357
1445
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
666.6
62.9
61
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
61.4
58
*
JFB30
NOMESCO Finland
Right hemicolectomy
57.3
61.4
72
14
WX408
NOMESCO Finland
General anesthesy, balanced
4.5
61.3
281
928
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
23.8
59.7
86
41
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
+∞
58.2
55
*
JAH00
NOMESCO Finland
Laparotomy
19.4
56.4
87
51
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
26.2
55.1
77
33
UJF32
NOMESCO Finland
Coloscopy
3.9
54.8
299
1130
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
559.5
53.2
52
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.9
53.0
284
1050
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
+∞
52.8
50
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
51.7
49
*
8249/3-C17.9
ICD-O-3
Neuroendocrine tumor, grade 2 of small intestine, NOS
+∞
51.7
49
*
A04AA01
ATC
ondansetron; systemic, rectal
16.0
51.3
85
60
8249/3-C17.2
ICD-O-3
Neuroendocrine tumor, grade 2 of ileum
+∞
49.6
47
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
32.8
45.7
60
20
JN3AD
NOMESCO Finland
Abdominal CT examination
6.7
45.5
125
222
B01AB10
ATC
tinzaparin; parenteral
8.7
45.4
103
137
L03AA02
ATC
filgrastim; parenteral
105.4
45.4
49
5
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
45.3
43
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
45.3
43
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.4
44.3
148
335
L03AA13
ATC
pegfilgrastim; parenteral
+∞
44.2
42
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
229.0
42.4
43
*
N02AA05
ATC
oxycodone; systemic
4.7
42.4
163
428
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
42.1
40
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
94.0
40.3
44
5
A09AA02
ATC
multienzymes (lipase, protease etc.)
18.3
39.7
62
37
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
50.3
39.3
47
10
8140/3-C17.0
ICD-O-3
Adenocarcinoma, NOS, of duodenum
+∞
38.9
37
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.2
38.8
99
157
JAH01
NOMESCO Finland
Laparoscopy
12.5
38.2
70
62
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.5
38.1
152
410
TPH04
NOMESCO Finland
Cathetrisation of vein
3.4
36.6
213
795
A79
ICPC
Malignancy NOS
133.9
36.1
38
*
JKA20
NOMESCO Finland
Cholecystectomy
10.7
36.0
71
73
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
34.7
33
*
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
60.5
34.6
40
7
115
Kela drug reimbursment
Breast cancer
+∞
33.6
32
*
PJA12
NOMESCO Finland
Sentinel node biopsy
342.8
33.2
33
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
24.6
32.7
46
20
302
Kela drug reimbursment
Interferon alfa
+∞
32.6
31
*
UJF30
NOMESCO Finland
Ileoscopy through colon
4.6
32.5
123
311
189
Kela drug reimbursment
Imatinib
+∞
31.5
30
*
WX402
NOMESCO Finland
General anaesthesia
4.0
31.4
142
425
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
22.8
31.3
45
21
WW500
NOMESCO Finland
Blood transfusion
11.9
31.1
58
53
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
30.4
29
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
30.4
29
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.6
30.4
82
139
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
16.6
29.9
48
31
116
Kela drug reimbursment
Prostate cancer
+∞
29.4
28
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
29.4
28
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
9.4
29.4
62
72
A02BC02
ATC
pantoprazole; systemic
2.6
29.2
490
3375
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
83.9
29.0
32
*
UJF92
NOMESCO Finland
Capsular endoscopy
12.7
28.9
52
44
JFB20
NOMESCO Finland
Ileocaecal resection
51.0
28.6
34
7
R4190
NOMESCO Finland
Nutritional therapy
12.1
28.3
52
46
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
28.3
27
*
T73
ICPC
Neoplasm endocrine other/unspecified
292.8
28.0
28
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
12.8
27.9
50
42
C10AC01
ATC
colestyramine; oral
8.9
27.7
60
73
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
27.3
26
*
L01AX03
ATC
temozolomide; systemic
+∞
27.3
26
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
27.3
351
2062
D64.9
ICD-10 Finland
Anaemia, unspecified
3.8
26.2
124
381
L01XE01
ATC
[U] imatinib; oral
+∞
26.2
25
*
WZC30
NOMESCO Finland
Teaching
3.8
25.9
121
368
L03AB05
ATC
interferon alfa-2b; parenteral
97.2
25.8
28
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
23.7
25.5
36
16
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.8
25.0
73
137
K56.7
ICD-10 Finland
Ileus, unspecified
13.5
24.2
42
33
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
24.1
23
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
24.1
23
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
24.1
23
*
8140/3-C17.9
ICD-O-3
Adenocarcinoma, NOS, of small intestine, NOS
+∞
23.0
22
*
9680/3-C17.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of small intestine, NOS
+∞
23.0
22
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
23.0
22
*
8246/3-C17.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of small intestine, NOS
+∞
23.0
22
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
41.6
22.8
28
7
JF1BD
NOMESCO Finland
Very extensive small bowel CT
28.4
22.4
30
11
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.6
22.4
46
51
D70.82
ICD-10 Finland
Drug-induced neutropenia
53.9
22.2
26
5
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.2
22.1
89
236
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
+∞
22.0
21
*
JN7SN
NOMESCO Finland
Somatostatin receptor SPECT
+∞
22.0
21
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
118.8
21.7
23
*
8240/3-C17.0
ICD-O-3
Neuroendocrine tumor, NOS, of duodenum
+∞
20.9
20
*
8936/3-C17.9
ICD-O-3
Gastrointestinal stromal tumor of small intestine, NOS
+∞
20.9
20
*
WF002
NOMESCO Finland
Radical radiotherapy
43.1
20.6
25
6
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
75.8
19.8
22
*
ZX120
NOMESCO Finland
Intravenous
3.8
19.6
87
251
HAB40
NOMESCO Finland
Wedge excision of mammary gland
41.4
19.6
24
6
L02BG04
ATC
letrozole; oral
47.5
19.3
23
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.9
19.1
83
235
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
18.8
18
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
18.8
18
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
102.9
18.6
20
*
R50.9
ICD-10 Finland
Fever, unspecified
3.1
18.6
114
421
XW000
NOMESCO Finland
Bone marrow biopsy
5.7
18.2
53
99
L02AE02
ATC
leuprorelin; implant, parenteral
27.6
17.9
24
9
N02BE01
ATC
paracetamol; systemic, rectal
2.5
17.9
582
4802
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
68.5
17.8
20
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
17.8
17
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
17.8
17
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
17.8
17
*
JFA73
NOMESCO Finland
Excision of lesion of small intestine
184.5
17.6
18
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
17.4
146
650
Y77
ICPC
Malignant neoplasm prostate
43.2
17.4
21
5
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.8
16.8
74
212
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
16.7
16
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
16.7
16
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
16.7
16
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
16.7
16
*
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
16.8
16.7
26
16
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.4
16.6
34
38
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
30.9
16.2
21
7
8246/3-C17.2
ICD-O-3
Neuroendocrine carcinoma, NOS, of ileum
+∞
15.7
15
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
15.7
15
*
9591/3-C17.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of small intestine, NOS
+∞
15.7
15
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
15.7
15
*
6402
FHL
Small bowel resection
87.1
15.6
17
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
163.5
15.5
16
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
163.5
15.5
16
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
10.8
15.3
29
28
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
15.1
131
591
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
14.6
14
*
A04AD12
ATC
aprepitant; systemic
+∞
14.6
14
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
14.6
14
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
14.6
14
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.6
14
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
14.6
14
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
14.6
14
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
14.5
127
577
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
27.8
14.3
19
7
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.6
14.2
49
112
D75
ICPC
Malignant neoplasm colon/rectum
43.4
14.2
17
*
HA1AA
NOMESCO Finland
X-ray mammography
6.0
13.9
38
66
K92.1
ICD-10 Finland
Melaena
3.8
13.9
61
174
ZX112
NOMESCO Finland
Subcutaneous
11.7
13.9
25
22
JN6AD
NOMESCO Finland
CT of torso and neck
54.5
13.9
16
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
5.5
13.8
41
79
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
13.8
90
341
8140/3-C17.2
ICD-O-3
Adenocarcinoma, NOS, of ileum
+∞
13.6
13
*
316
Kela drug reimbursment
Imatinib
+∞
13.6
13
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
13.6
13
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
13.6
13
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
13.6
13
*
197
Kela drug reimbursment
Sunitinib
+∞
13.6
13
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
13.6
13
*
C17
ICD-10 Finland
Malignant neoplasm of small intestine
+∞
13.6
13
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.9
13.6
44
94
R11
ICD-10 Finland
Nausea and vomiting
3.3
13.6
70
228
NK6AN
NOMESCO Finland
Total body bone isotope imaging
34.8
13.5
17
5
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.6
13.4
34
54
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
10.0
13.3
26
27
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
15.4
13.2
21
14
SPAT1153
SPAT
Removal of sutures
1.9
13.1
232
1429
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
51.0
12.9
15
*
K56.0
ICD-10 Finland
Paralytic ileus
9.9
12.8
25
26
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.3
12.6
38
75
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
32.7
12.6
16
5
XX9AD
NOMESCO Finland
Complementary CT
+∞
12.5
12
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.5
12
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
12.5
12
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
12.5
12
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
12.5
12
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
12.5
12
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
12.5
12
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
12.2
45
110
WX600
NOMESCO Finland
Single shot through catheter
16.2
12.2
19
12
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
11.9
94
401
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
30.6
11.7
15
5
R10.0
ICD-10 Finland
Acute abdomen
5.3
11.7
35
69
JFB01
NOMESCO Finland
Laparoscopic partial resection of small intestine
66.1
11.6
13
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
11.5
75
286
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
13.9
11.5
19
14
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
11.5
11
*
8140/3-C17.1
ICD-O-3
Adenocarcinoma, NOS, of jejunum
+∞
11.5
11
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
11.5
11
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
11.5
11
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
11.5
11
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
11.5
11
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
11.5
11
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
11.5
11
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
11.5
11
*
9680/3-C17.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of ileum
+∞
11.5
11
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
11.5
11
*
L01XE04
ATC
[U] sunitinib; oral
+∞
11.5
11
*
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
11.5
11
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.5
11
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
121.9
11.5
12
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
9.8
11.3
22
23
A06AH03
ATC
naloxegol; oral
35.7
11.3
14
*
J01MA02
ATC
ciprofloxacin; systemic
1.8
11.3
275
1868
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.6
11.3
50
145
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
20.4
11.2
16
8
Z51.88
ICD-10 Finland
Other specified medical care
6.3
11.2
29
48
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.9
11.1
45
121
ZX114
NOMESCO Finland
Intramuscular
10.3
11.1
21
21
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
44.0
10.9
13
*
B03BA03
ATC
hydroxocobalamin; parenteral
3.2
10.9
58
194
M04AA01
ATC
allopurinol; systemic
2.2
10.8
117
584
KCD02
NOMESCO Finland
Transurethral resection of bladder
21.9
10.7
15
7
JEA00
NOMESCO Finland
Appendectomy
3.4
10.7
52
163
JDE00
NOMESCO Finland
Gastrojejunostomy
60.9
10.6
12
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
6.7
10.6
26
40
UJF02
NOMESCO Finland
Peroral enteroscopy
14.5
10.5
17
12
WF003
NOMESCO Finland
Adjuvant radiotherapy
111.6
10.4
11
*
JJA20
NOMESCO Finland
Open biopsy of liver
111.6
10.4
11
*
9680/3-C17.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of duodenum
+∞
10.4
10
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
10.4
10
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.4
10
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
10.4
10
*
1522B
ICD-9 Finland
Malignant neoplasm of small intestine, including duodenum, Ileum[NEOPLASMA MALIGNUM ILEI,ALIA DEFINITA SEU NUD]
+∞
10.4
10
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
10.4
10
*
L02BB03
ATC
bicalutamide; oral
+∞
10.4
10
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
10.4
10
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
10.4
10
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
10.4
10
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
10.4
10
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
10.4
10
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
10.4
10
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
10.4
10
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
10.4
284
1988
R4110
NOMESCO Finland
Physiotherapy
1.9
10.4
183
1111
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
10.8
10.3
19
18
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.1
10.3
55
185
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.1
10.2
39
100
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
10.2
142
789
WX704
NOMESCO Finland
Intubation
3.1
10.0
56
192
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
40.7
10.0
12
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
55.8
9.7
11
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
55.8
9.7
11
*
K65.0
ICD-10 Finland
Acute peritonitis
8.5
9.6
20
24
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
7.3
9.6
22
31
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.3
9.6
22
31
L02BA01
ATC
tamoxifen; oral
101.3
9.4
10
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
9.4
120
640
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
30.5
9.4
12
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
9.4
9
*
176
Kela drug reimbursment
Regorafenib
+∞
9.4
9
*
8936/3-C17.1
ICD-O-3
Gastrointestinal stromal tumor of jejunum
+∞
9.4
9
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
22.0
9.4
13
6
B01AB04
ATC
dalteparin; parenteral
3.4
9.4
45
140
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.6
9.3
26
48
A06AD11
ATC
lactulose; oral
2.1
9.1
110
574
N02AX02
ATC
tramadol; systemic, rectal
1.7
9.0
286
2066
B81
ICPC
Anaemia vit B12/folate deficiency
3.7
8.9
38
108
107
Kela drug reimbursment
Pernicious anaemia
5.5
8.8
25
47
J01MA12
ATC
levofloxacin; systemic
1.9
8.8
130
737
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.2
8.7
45
148
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
14.3
8.7
14
10
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
16.5
8.6
13
8
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.8
8.6
35
96
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
91.1
8.4
9
*
JFC00
NOMESCO Finland
Entero-enterostomy
91.1
8.4
9
*
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
91.1
8.4
9
*
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
+∞
8.3
8
*
9717/3-C17.9
ICD-O-3
Intestinal T-cell lymphoma of small intestine, NOS
+∞
8.3
8
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
8.3
8
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
8.3
8
*
JN5SR
NOMESCO Finland
Very extensive PET-CT of receptors in upper body
+∞
8.3
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
8.3
8
*
369
Kela drug reimbursment
Regorafenib
+∞
8.3
8
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
8.3
8
*
8240/3-C17.1
ICD-O-3
Neuroendocrine tumor, NOS, of jejunum
+∞
8.3
8
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
+∞
8.3
8
*
127
Kela drug reimbursment
Transplant complication
8.7
8.3
17
20
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.3
8.3
40
126
K50.9
ICD-10 Finland
Crohn disease, unspecified
6.9
8.1
19
28
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
22.3
8.0
11
5
1XC02
NOMESCO Finland
NA
22.3
8.0
11
5
WX892
NOMESCO Finland
Monitored bed care
2.6
8.0
60
248
K50.0
ICD-10 Finland
Crohn disease of small intestine
6.5
7.8
19
30
K90.0
ICD-10 Finland
Coeliac disease
3.9
7.7
30
79
JFF10
NOMESCO Finland
Loop enterostomy
45.5
7.7
9
*
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
45.5
7.7
9
*
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.7
241
1712
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
12.0
7.6
13
11
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
5.5
7.6
21
39
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.0
7.5
43
151
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
3.6
7.5
32
92
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
80.9
7.4
8
*
S55
ICPC
Skin, Local injection/infiltration
80.9
7.4
8
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
7.8
7.4
16
21
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
11.0
7.3
13
12
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
7.3
7
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C17.3
ICD-10 Finland
Malignant neoplasm: Meckel diverticulum
+∞
7.3
7
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.3
7
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
7.3
7
*
E340, C179
ICD-10 Finland
NA
+∞
7.3
7
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
7.3
7
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.9
7.3
19
33
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.9
7.2
42
151
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
20.3
7.1
10
5
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
20.3
7.1
10
5
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.0
7.1
15
19
3AC01
NOMESCO Finland
NA
7.1
7.0
16
23
J01DB01
ATC
cefalexin; oral
1.6
6.9
509
4417
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.6
6.9
15
20
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
8.4
6.8
14
17
A55
ICPC
General and Unspecified, Local injection/infiltration
8.4
6.8
14
17
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
6.8
152
980
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
40.4
6.8
8
*
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
40.4
6.8
8
*
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
40.4
6.8
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
40.4
6.8
8
*
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
3.0
6.8
36
123
PJA10
NOMESCO Finland
Exploration of lymph nodes
22.8
6.7
9
*
5609X
ICD-9 Finland
Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction
22.8
6.7
9
*
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
7.9
6.6
14
18
S18
ICPC
Laceration/cut
1.5
6.6
264
1979
JAL30
NOMESCO Finland
Omentectomy
12.4
6.6
11
9
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.9
6.6
20
42
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
70.4
6.4
7
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
14.5
6.4
10
7
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
14.5
6.4
10
7
JFB43
NOMESCO Finland
Left hemicolectomy
14.5
6.4
10
7
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
6.6
6.4
15
23
B80
ICPC
Iron deficiency anaemia
4.6
6.3
20
44
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.5
6.3
27
79
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
18.2
6.3
9
5
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
18.2
6.3
9
5
JF1AD
NOMESCO Finland
Small bowel CT
18.2
6.3
9
5
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
6.3
6
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
6.3
6
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
6.3
6
*
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.3
6
*
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
6.3
6
*
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
L01XE21
ATC
[U] regorafenib; oral
+∞
6.3
6
*
9691/3-C17.9
ICD-O-3
Follicular lymphoma, grade 2 of small intestine, NOS
+∞
6.3
6
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
6.2
138
885
D99
ICPC
Disease digestive system other
7.1
6.2
14
20
6101
FHL
Exploratory laparotomy, includes possible biopases
26.9
6.2
8
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
26.9
6.2
8
*
-50
ICPC
Medication/prescr/renewal
2.9
6.2
36
129
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
6.1
83
453
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.1
6.1
22
55
C03CA01
ATC
furosemide; systemic
1.6
6.1
209
1504
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
6.1
196
1387
WX110
NOMESCO Finland
Local anesthesy
1.5
6.1
387
3193
TQW99
NOMESCO Finland
Other minor procedure on skin
3.3
6.1
28
87
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.9
6.0
35
126
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.9
6.0
23
61
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
6.0
52
235
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
6.0
72
375
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
448
438
17.03
307.65
4.9
1.4
ug/l
10.5
3.5
1.27
370
333
(4035726)
376
242
23.58
307.65
1.6
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
216
166
16.10
234.03
4.1
1.9
u/ml
160.4
86.5
0.28
194
128
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
127
87
16.46
144.84
3.8
1.7
u/ml
123.4
60.3
0.68
116
80
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
825
3997
5.86
140.41
16.2
3.8
umol/l
11.9
12.1
0.15
814
3749
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
296
630
6.14
139.18
3.3
2.0
g/l
0.2
0.2
1.73
285
570
(3024561) Albumin [Mass/volume] in Serum or Plasma
737
3496
4.67
122.26
10.6
3.7
g/l
34.1
35.6
9.71
722
3207
(3033658) Prothrombin time (PT) actual/Normal
498
1949
3.94
104.34
6.6
3.4
%
86.2
85.9
0.09
491
1895
(3013650) Neutrophils [#/volume] in Blood by Automated count
789
4424
4.10
91.90
18.4
6.5
e9/l
3.7
4.3
13.16
735
3813
(3044640) Blood type and Crossmatch panel - Blood
526
2340
3.49
86.84
3.4
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
232
595
4.72
84.98
1.4
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
271
820
4.10
79.39
3.8
2.3
umol/l
8.6
8.8
0.05
250
706
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
738
4192
3.53
78.88
10.0
5.6
mmol/l
1.2
1.2
8.31
622
3564
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
671
3617
3.35
77.89
5.5
3.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
686
3794
3.31
75.27
8.4
5.1
mmol/l
1.2
1.2
5.14
658
3357
(3012095) Magnesium [Moles/volume] in Serum or Plasma
333
1212
3.55
73.70
6.7
2.7
mmol/l
0.8
0.8
4.78
321
1114
(3000570) Elastase.pancreatic [Mass/mass] in Stool
130
227
6.39
72.87
1.5
1.4
ug/g
208.8
296.8
4.92
97
129
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
265
842
3.87
71.80
5.9
3.0
u/l
229.2
240.5
1.05
251
787
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
303
1072
3.56
69.64
2.6
2.5
%
20.1
23.1
2.25
264
915
(40768804) Tissue Pathology biopsy report
521
2562
3.04
68.30
2.7
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
416
1818
3.13
67.04
14.0
5.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
331
1277
3.32
65.77
2.7
2.4
umol/l
11.5
13.2
2.90
318
1173
(3018418) pH of Serum or Plasma
498
2427
2.99
65.73
6.1
3.2
ph
7.4
7.4
0.06
116
400
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
415
1832
3.08
65.41
3.0
2.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
310
1159
3.37
64.72
2.6
2.4
g/l
2.4
2.3
1.07
301
1075
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
515
2573
2.95
64.67
3.9
2.2
u/l
57.7
58.2
0.07
490
2358
(3015377) Calcium [Moles/volume] in Serum or Plasma
520
2648
2.90
62.44
7.7
2.0
mmol/l
2.3
2.4
3.46
485
2177
(42870588) Differential panel, method unspecified - Blood
519
2675
2.85
60.37
9.0
5.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
904
6361
3.93
58.35
20.2
5.4
u/l
91.2
76.0
8.59
894
5863
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
489
2478
2.81
58.23
5.5
2.6
u/l
33.9
32.8
0.22
474
2358
(3014576) Chloride [Moles/volume] in Serum or Plasma
277
1040
3.25
56.61
8.1
6.0
mmol/l
104.4
104.4
0.03
272
1010
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
211
675
3.66
55.52
3.5
2.0
u/l
40.5
44.3
0.14
195
560
(3032080) INR in Blood by Coagulation assay
610
3525
2.73
55.13
10.1
10.5
inr
1.2
1.3
3.10
188
971
(3023368) Bacteria identified in Blood by Culture
448
2221
2.77
54.94
6.2
4.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
631
3784
2.66
51.69
9.5
5.8
%
26.1
27.2
1.77
597
3494
(3022096) Basophils/100 leukocytes in Blood
609
3602
2.63
51.13
9.5
5.7
%
0.7
0.7
0.04
574
3329
(3006504) Eosinophils/100 leukocytes in Blood
621
3712
2.63
50.94
9.4
5.7
%
3.1
2.9
0.87
586
3423
(3019069) Monocytes/100 leukocytes in Blood
621
3724
2.62
50.40
9.6
5.9
%
9.3
8.8
4.12
587
3454
(3018010) Neutrophils/100 leukocytes in Blood
619
3749
2.57
48.53
9.3
5.6
%
58.4
57.8
0.63
584
3480
(3013826) Glucose [Moles/volume] in Serum or Plasma
749
4973
2.74
48.44
7.2
4.4
mmol/l
6.7
6.8
0.75
729
4657
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
174
538
3.67
47.78
2.0
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
419
2150
2.57
46.18
2.8
2.2
mg/l
3.4
3.0
2.38
379
1806
(3019198) Lymphocytes [#/volume] in Blood
647
4073
2.52
45.58
9.4
5.5
e9/l
1.7
1.9
3.12
583
3542
(3001604) Monocytes [#/volume] in Blood
637
3990
2.50
45.23
9.3
5.4
e9/l
0.6
0.6
0.77
567
3411
(3006315) Basophils [#/volume] in Blood
638
4008
2.50
44.87
9.3
5.4
e9/l
0.0
0.0
3.16
566
3431
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
29
10
29.79
43.34
1.4
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
648
4145
2.46
43.10
9.8
5.7
e9/l
0.2
0.2
0.44
581
3599
(3003458) Phosphate [Moles/volume] in Serum or Plasma
258
1090
2.81
41.39
7.7
4.8
mmol/l
1.0
1.0
0.01
247
994
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
46
6
80.20
41.22
2.1
1.8
pmol/l
48.6
51.9
—
36
6
(40768795) Lymph node Pathology biopsy report
35
22
16.42
41.05
1.2
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
207
784
3.04
40.51
1.5
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
438
2431
2.37
39.19
4.0
3.1
e6/l
32.4
96.6
1.52
363
1871
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
67
111
6.38
39.18
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
264
1163
2.69
38.78
1.5
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
318
1538
2.53
38.51
6.2
2.1
mmol/l
2.4
2.4
0.23
299
1319
(3030467) Casts [#/volume] in Urine by Automated count
409
2222
2.37
38.23
3.9
3.0
e6/l
0.6
0.4
0.58
335
1683
(3026782) Osmolality of Urine
320
1558
2.51
38.15
3.3
2.6
mosm/kgh2o
560.5
551.3
0.31
288
1303
(40768441) Liver Pathology biopsy report
41
40
10.62
37.08
1.1
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
187
710
2.99
36.17
8.0
6.8
mmol/l
9.5
10.5
0.92
182
670
(3000850) Epithelial cells [#/volume] in Urine
334
1698
2.41
35.89
2.9
2.4
e6/l
5.2
5.6
0.18
293
1480
(36304419) Bacteria [Presence] in Urine
392
2156
2.30
34.96
3.9
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
544
3556
2.09
30.05
19.8
8.6
e9/l
0.0
0.0
0.74
473
2890
(3002173) Hemoglobin [Mass/volume] in Arterial blood
192
815
2.66
29.70
6.0
7.3
g/l
118.6
122.5
1.60
182
790
(3018095) Leukocytes [#/volume] in Urine
463
2865
2.10
29.47
4.7
3.5
e6/l
316.0
114.8
0.68
370
2030
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
126
434
3.16
28.58
6.9
9.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
200
889
2.54
28.04
5.9
6.9
%
96.1
95.0
1.29
190
862
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
215
990
2.47
27.95
5.7
6.7
kpa
5.1
5.1
0.43
204
954
(3027801) Oxygen [Partial pressure] in Arterial blood
215
990
2.47
27.95
5.7
6.7
kpa
13.6
11.5
6.55
203
952
(3003396) Base excess in Arterial blood by calculation
214
992
2.45
27.37
5.7
6.6
mmol/l
0.1
1.3
3.17
165
770
(3001122) Ferritin [Mass/volume] in Serum or Plasma
511
3352
2.02
27.01
3.7
2.7
ug/l
144.9
136.5
0.32
479
3048
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
86
248
3.69
25.75
2.9
2.6
u/ml
0.3
0.4
1.11
49
149
(3027945) Reticulocytes/100 erythrocytes in Blood
213
1028
2.34
24.67
2.6
2.2
%
1.8
1.8
0.19
193
905
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
245
1268
2.21
23.95
3.6
2.8
e6/l
2.9
2.3
0.38
136
698
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
443
2851
1.95
23.89
3.8
3.0
ng/l
1575.7
1525.2
0.07
399
2433
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
687
5142
1.96
23.29
5.3
3.0
u/l
70.8
49.1
5.77
662
4723
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
180
830
2.41
23.01
3.4
3.1
ng/l
132.4
215.3
4.22
167
767
(3000991) Gas panel - Venous blood
159
695
2.52
22.82
7.5
7.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
228
1168
2.21
22.75
2.3
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
149
636
2.56
22.46
5.6
2.8
mmol/l
1.2
1.2
1.48
144
531
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
157
692
2.49
22.10
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
148
651
2.48
20.87
1.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
36
62
5.98
20.19
1.5
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
26
32
8.30
19.70
2.7
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
50
118
4.40
19.66
7.6
6.3
iu/ml
509.0
459.9
—
6
16
(3031040) Bacteria [#/volume] in Urine by Automated count
699
5447
1.84
18.80
5.4
4.4
e6/l
1035.8
2329.6
—
10
80
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
246
1389
2.01
18.60
3.4
2.6
e6/l
1.4
1.4
0.02
139
815
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
35
7.59
18.29
2.6
1.7
%
17.8
16.1
0.16
11
16
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
70
227
3.23
17.44
1.4
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
28
44
6.51
17.16
3.3
1.5
e9/l
1.0
1.0
0.11
21
25
(4281824)
26
39
6.81
16.63
1.1
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
97
388
2.65
16.56
1.4
1.6
g/l
1.6
1.5
0.60
79
335
(3021879) Hepatitis B virus core Ab [Presence] in Serum
98
397
2.62
16.31
1.2
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
155
775
2.17
16.05
2.7
2.3
e9/l
67.2
69.3
0.29
122
605
(3037467) Urinalysis macro (dipstick) panel - Urine
715
5749
1.75
15.77
4.9
4.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
375
2539
1.74
15.47
3.4
3.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
474
3426
1.70
15.37
3.0
2.3
nmol/l
71.5
78.5
6.47
447
2975
(3003694) ABO and Rh group [Type] in Blood
309
1983
1.79
15.33
1.4
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
141
704
2.16
14.60
3.6
1.6
g/l
64.9
67.2
2.24
128
631
(3005719) IgG [Mass/volume] in Serum or Plasma
117
543
2.30
14.48
3.4
2.2
g/l
9.3
10.9
4.44
110
500
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
177
978
1.97
13.91
1.9
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
92
391
2.48
13.85
1.4
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
15
14
10.85
13.77
1.8
2.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
229
1382
1.84
13.74
2.2
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
176
979
1.96
13.54
1.9
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
505
3825
1.61
12.87
2.4
2.0
pmol/l
87.8
94.0
2.48
316
1953
(3008152) Bicarbonate [Moles/volume] in Arterial blood
118
577
2.18
12.84
6.1
6.7
mmol/l
24.0
24.5
0.76
105
543
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
59
208
2.95
12.77
2.1
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
31
71
4.47
12.68
2.0
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
49
156
3.25
12.61
5.4
4.4
mmol/l
4.5
2.8
2.25
34
106
(21494814) CD8 cells/100 lymphocytes in Specimen
15
16
9.50
12.57
2.4
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
17
7
24.64
12.48
5.5
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
94
3.93
12.43
1.9
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
155
852
1.96
12.29
6.8
3.2
kpa
5.7
5.8
0.95
150
823
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
39
109
3.68
12.24
2.7
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
21
35
6.10
12.16
1.1
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
64
244
2.73
12.00
3.6
3.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
155
859
1.94
11.98
1.4
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
122
626
2.07
11.70
5.3
3.9
%
0.7
0.8
0.12
49
139
(3019060) Gas panel - Arterial blood
117
596
2.08
11.44
4.7
4.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
117
596
2.08
11.44
5.4
4.0
%
0.1
0.1
0.52
45
122
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
47
155
3.13
11.43
2.8
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
113
569
2.10
11.39
5.0
3.8
%
0.5
0.5
0.08
37
104
(3021960) Folate [Moles/volume] in Serum or Plasma
319
2217
1.63
11.20
1.8
1.5
nmol/l
21.1
20.5
0.28
296
1858
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
83
371
2.34
11.18
5.6
4.6
%
1.5
1.6
0.62
76
356
(3028026) IgM [Mass/volume] in Serum or Plasma
94
444
2.23
11.12
1.8
1.3
g/l
1.3
1.2
0.14
88
405
(3002032) Base excess in Venous blood by calculation
151
851
1.90
11.07
6.9
3.2
mmol/l
2.0
2.1
0.12
123
686
(3047181) Lactate [Moles/volume] in Blood
67
273
2.55
11.02
5.6
6.0
mmol/l
1.5
1.3
0.83
52
249
(3007930) Methemoglobin/Hemoglobin.total in Blood
81
363
2.33
10.85
5.6
4.7
%
0.9
0.9
0.17
74
348
(3048689) Calprotectin [Mass/mass] in Stool
150
853
1.88
10.68
2.2
2.2
ug/g
242.0
148.8
1.28
129
672
(3051651) Icteric interference index of Serum or Plasma
21
40
5.34
10.62
2.8
3.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
75
328
2.38
10.62
1.9
1.7
ug/l
2.8
1.8
0.27
65
288
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
12
10.10
10.45
2.2
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
150
863
1.86
10.29
5.0
3.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
38
118
3.30
10.21
1.2
1.2
nmol/l
0.1
0.5
—
5
10
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
104
3.45
10.07
1.2
1.2
nmol/l
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
266
1809
1.63
10.03
1.8
1.8
nmol/l
1301.4
1170.7
1.12
211
1353
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
46
162
2.92
10.01
2.6
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
38
120
3.25
9.94
1.2
1.2
nmol/l
0.6
0.6
0.01
38
112
(3039000) Anion gap in Blood
50
189
2.73
9.57
6.6
6.7
mmol/l
10.7
11.1
0.57
44
175
(3018572) Chloride [Moles/volume] in Blood
50
189
2.73
9.57
6.6
6.7
mmol/l
104.1
105.5
0.82
44
175
(1616796) Gas panel - Central venous blood
45
162
2.86
9.43
4.4
3.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
107
572
1.97
9.14
5.6
4.0
%
0.2
0.9
0.43
39
112
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
917
8319
1.78
9.10
31.5
13.1
mg/l
30.9
23.9
8.67
856
6472
(3042111) Morphology [Interpretation] in Bone marrow Narrative
35
112
3.20
8.98
1.8
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
54
220
2.53
8.92
1.1
1.1
titre
—
1816.3
—
0
8
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
35
5.21
8.90
1.9
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
35
5.21
8.90
1.9
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
34
108
3.22
8.83
1.5
1.3
u/ml
94.6
107.0
—
8
16
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
34
109
3.19
8.71
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
44
4.61
8.61
1.8
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
717
6181
1.50
8.38
5.0
4.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
22
54
4.14
8.29
1.5
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
28
82
3.48
8.26
2.9
3.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
124
719
1.82
8.26
2.5
1.8
nmol/l
400.7
360.6
0.72
114
643
(40761536) Microorganisms panel - Urine sediment
112
629
1.87
8.25
4.5
3.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
17
34
5.07
8.16
5.7
1.1
u/ml
45.6
52.4
—
7
8
(3035637) Corticotropin [Mass/volume] in Plasma
24
64
3.81
8.10
1.8
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
311
2290
1.51
8.01
4.4
2.5
umol/l
2078.6
6790.8
1.64
284
1957
(3037121) Protein [Mass/volume] in Urine
59
268
2.27
7.70
4.9
2.6
g/l
0.3
0.2
0.40
44
86
(3002385) Erythrocyte distribution width [Ratio]
767
6751
1.50
7.69
41.8
15.9
%
14.5
13.7
22.98
758
6573
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
53
4.02
7.64
2.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
771
8480
0.66
7.60
4.2
4.8
mmol/l
1.4
1.4
2.56
688
7736
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
15
7.40
7.56
1.2
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
802
8749
0.65
7.55
4.5
5.4
mmol/l
2.5
2.7
5.35
709
8002
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
742
8220
0.67
7.55
3.9
4.3
mmol/l
1.3
1.3
0.91
655
7430
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
780
8556
0.66
7.53
4.2
4.8
mmol/l
4.3
4.5
5.95
699
7857
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
29
5.23
7.46
3.5
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
119
704
1.78
7.41
6.6
2.6
kpa
4.3
4.6
1.02
113
676
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
117
690
1.78
7.36
4.3
3.8
ng/l
107.7
89.8
1.24
104
599
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
92
505
1.90
7.28
1.7
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20
51
3.98
7.18
1.4
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
43
175
2.52
7.16
2.9
2.5
%
14.1
16.5
1.74
23
93
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
10
5
20.17
7.14
1.5
1.0
u/ml
58.5
14.8
—
10
5
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
10
5
20.17
7.14
1.3
1.8
pmol/l
10.2
11.7
—
10
5
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
33
118
2.85
7.05
1.3
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
125
2.78
6.91
1.5
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
18
44
4.14
6.83
1.2
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
17
6.53
6.78
2.4
2.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
77
408
1.96
6.77
2.8
3.1
pmol/l
4.1
4.5
2.85
68
351
(40768793) Breast Pathology biopsy report
20
54
3.76
6.66
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
84
466
1.87
6.45
2.8
2.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
22
65
3.44
6.44
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
234
1690
1.49
6.44
5.7
4.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
144
934
1.63
6.38
1.8
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
22
67
3.33
6.16
1.5
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
22
67
3.33
6.16
1.5
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
41
177
2.37
6.06
2.8
2.6
umol/l
33.3
34.1
0.08
33
152
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
190
2.32
6.04
1.6
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
25
84
3.02
5.98
3.4
3.5
%
1.7
0.9
0.55
19
63
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
242
1785
1.46
5.94
4.1
3.9
ng/l
150.3
520.2
4.02
198
1475
(3007164) IgA [Mass/volume] in Serum or Plasma
199
1414
1.50
5.89
1.6
1.3
g/l
2.4
2.7
1.88
136
825
(3028308) Erythrocytes [#/volume] in Pleural fluid
23
75
3.11
5.79
1.5
1.5
e6/l
13358.1
118823.7
—
9
44
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
31
120
2.63
5.75
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
490
4106
1.36
5.65
5.7
4.9
estimate
0.0
0.0
0.00
133
687
(3049717) Cytology report of Urine Cyto stain
59
304
2.00
5.65
4.1
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
275
2101
1.42
5.54
4.3
3.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
181
1281
1.50
5.44
22.9
29.1
inr
1.3
1.4
0.40
32
177
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
5
16.11
5.41
2.5
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
24
84
2.90
5.38
1.5
1.5
e6/l
9977.4
2039.0
0.40
12
60
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
34
4.16
5.37
3.8
1.5
e6/l
283.6
984.4
—
5
13
(40765096) Chromosome analysis panel by Banding
10
18
5.60
5.33
1.1
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
126
2.50
5.24
1.9
1.4
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
491
4152
1.34
5.18
4.3
3.6
estimate
0.0
0.0
0.80
136
668
(3030905) Polymorphonuclear cells [#/volume] in Blood
33
139
2.42
5.18
2.6
3.1
e9/l
3.5
4.4
1.79
33
139
(3004588) Protein electrophoresis panel - Serum or Plasma
98
609
1.67
5.14
2.2
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
484
4088
1.34
5.13
4.2
3.6
estimate
0.0
0.0
0.00
134
685
(3024980) IgG subclass 4 [Mass/volume] in Serum
28
110
2.59
5.08
1.5
1.7
g/l
0.9
1.0
0.10
18
89
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
14
36
3.93
4.99
1.1
1.1
u/l
144.3
92.4
0.73
14
31
(3021901) Oxygen saturation in Capillary blood
36
161
2.28
4.96
3.1
2.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
25
94
2.70
4.94
1.8
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
30
124
2.46
4.91
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
33
143
2.35
4.88
3.3
3.2
%
53.9
58.8
1.23
33
143
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
20
5.04
4.78
1.9
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
108
2.54
4.74
1.7
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
56
304
1.89
4.65
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
99
2.56
4.49
2.0
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
42
209
2.05
4.47
1.3
1.7
—
—
—
0
0
(44806118)
22
82
2.72
4.44
1.6
1.6
—
—
—
0
0
(44790048)
22
82
2.72
4.44
1.6
1.6
—
—
—
0
0
(44790047)
22
82
2.72
4.44
1.6
1.6
—
—
—
0
0
(44790049)
22
82
2.72
4.44
1.6
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
32
144
2.26
4.38
1.9
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
703
6354
1.32
4.25
4.6
4.2
mm/h
17.5
12.2
9.87
652
5835
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
331
1.80
4.15
2.3
1.4
g/l
3.4
3.1
1.07
41
260
(3029937) Albumin [Presence] in Urine by Test strip
278
2228
1.34
4.01
4.4
3.9
estimate
0.0
0.0
0.50
120
666
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
223
1730
1.37
3.98
1.9
1.7
mg/l
1.4
1.2
0.59
174
1342
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
49
3.09
3.81
1.7
1.8
—
—
—
0
0
(3020891) Body temperature
62
373
1.70
3.72
4.6
4.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
33
162
2.07
3.69
1.8
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
40
3.28
3.63
1.4
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
361
1.70
3.61
2.2
1.4
g/l
7.5
7.5
0.08
41
267
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
361
1.70
3.61
2.2
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
361
1.70
3.61
2.2
1.4
g/l
4.0
3.9
0.24
40
258
(3030981) Hyaline casts [#/volume] in Urine by Automated count
70
439
1.64
3.60
3.2
2.5
e6/l
0.4
0.2
0.34
70
426
(3003181) Sodium [Moles/volume] in Urine
31
150
2.10
3.60
1.8
1.4
mmol/l
62.5
64.8
0.11
24
119
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
26
117
2.25
3.60
1.5
1.2
u/ml
339.9
268.7
0.43
15
65
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
35
178
2.00
3.57
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
35
178
2.00
3.57
1.2
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
63
2.73
3.50
1.5
1.8
u/l
2.0
90.8
—
5
22
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
31
3.58
3.49
1.2
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
12
36
3.36
3.48
1.3
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
407
3488
1.27
3.47
4.0
3.8
ng/l
62.7
64.0
0.02
300
2555
(1761868) Lipid panel - Serum or Plasma
226
2796
0.76
3.41
2.9
3.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
207
1626
1.34
3.38
1.3
1.2
u/ml
1.9
2.0
0.06
51
440
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
59
2.74
3.33
1.9
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
18
72
2.53
3.22
3.1
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
248
2013
1.30
3.20
1.9
1.7
pmol/l
75000408.9
22539921.7
0.47
212
1646
(3023103) Potassium [Moles/volume] in Serum or Plasma
934
8918
1.41
3.18
36.6
16.0
mmol/l
3.9
4.0
12.09
925
8663
(3019550) Sodium [Moles/volume] in Serum or Plasma
932
8897
1.40
3.16
36.7
15.9
mmol/l
139.3
139.8
6.03
923
8655
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
36
194
1.89
3.14
1.1
1.1
u/ml
2.0
14.9
—
6
18
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
44
2.98
3.14
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
791
7380
1.29
3.12
34.9
14.7
%
37.4
39.7
10.39
561
4841
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
12
39
3.10
3.09
2.3
2.1
ug/l
47.7
53.1
0.28
12
39
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
39
3.10
3.09
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
74
2.46
3.06
3.8
1.3
—
—
—
0
0
(4062490)
17
68
2.52
3.05
1.1
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
66
428
1.58
3.00
6.1
2.3
%
1.1
1.2
0.13
66
428
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
127
2.07
2.99
1.5
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
49
295
1.69
2.98
2.6
1.4
g/l
0.8
0.4
0.46
42
254
(3027135) IgG subclass 1 [Mass/volume] in Serum
17
69
2.49
2.97
1.1
1.2
g/l
6.3
6.9
—
9
52
(3024139) IgG subclass 3 [Mass/volume] in Serum
17
69
2.49
2.97
1.1
1.2
g/l
0.4
0.4
—
9
51
(3028192) IgG subclass 2 [Mass/volume] in Serum
17
69
2.49
2.97
1.1
1.2
g/l
2.7
2.8
—
9
52
(40760888) Immunoglobulin light chains.free panel - Serum
35
191
1.86
2.95
4.7
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
845
7971
1.30
2.93
32.4
12.1
ml/min/173m2
76.9
76.5
0.22
796
6428
(3033799) Differential panel - Peritoneal fluid
8
17
4.73
2.92
2.6
1.9
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
12
41
2.95
2.86
3.1
2.0
%
34.0
45.8
—
6
17
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
338
1.63
2.85
2.3
1.4
g/l
10.0
10.6
0.48
43
286
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
46
276
1.70
2.85
1.5
1.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
73
0.00
2.78
0.0
1.0
—
46.5
—
0
43
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
73
0.00
2.78
0.0
1.0
—
323.2
—
0
45
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
73
0.00
2.78
0.0
1.0
—
619.6
—
0
42
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
79
543
1.49
2.78
1.8
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
66
2.45
2.72
3.6
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
39
227
1.75
2.70
3.7
3.1
mmol/l
23.5
25.0
1.26
32
196
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
161
1.89
2.68
1.5
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
21
99
2.14
2.66
1.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
32
3.15
2.65
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
32
3.15
2.65
1.4
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
43
259
1.69
2.64
5.3
1.4
mg/l
53.4
34.8
0.56
34
210
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
162
1.88
2.64
1.5
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
55
2.57
2.62
1.5
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
260
1.68
2.61
5.3
1.4
mg/l
60.4
44.7
0.64
35
211
(40761511) CBC panel - Blood by Automated count
908
8684
1.33
2.60
29.1
12.9
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
25
3.62
2.58
2.3
2.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
20
4.02
2.57
1.9
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
363
3155
1.23
2.57
4.6
3.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
16
68
2.37
2.56
4.8
3.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
44
2.75
2.55
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
44
2.75
2.55
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
198
2408
0.78
2.53
1.7
1.6
mmol/l
1.4
1.4
0.18
164
2007
(3019225) pH of Specimen
116
877
1.36
2.44
6.5
3.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
77
542
1.45
2.44
5.4
3.5
mmol/l
1.5
1.9
0.35
52
400
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
12
5.02
2.40
1.5
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
12
5.02
2.40
1.2
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
27
3.35
2.39
1.0
1.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
52
2.52
2.36
2.0
2.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
45
284
1.61
2.34
2.2
1.3
g/l
36.5
37.6
0.52
37
239
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
177
1.77
2.32
1.1
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
80
574
1.43
2.30
5.5
3.5
kpa
5.0
5.2
1.03
74
525
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
687
6399
1.21
2.29
4.6
3.8
pmol/l
14.5
14.9
4.32
632
5757
(3043410) Blood group antigens tested for on Red Blood Cells
8
23
3.50
2.27
2.4
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
23
3.50
2.27
1.9
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
120
1.94
2.27
2.7
2.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
33
194
1.72
2.25
9.0
2.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
126
979
1.33
2.23
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
93
2.06
2.22
1.7
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
817
8545
0.81
2.21
5.6
4.9
mmol/l
6.2
6.1
1.42
762
7710
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
48
2.52
2.19
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
48
2.52
2.19
1.0
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
78
563
1.42
2.18
5.5
3.5
ph
7.4
7.4
0.03
17
67
(3024891) Influenza virus A+B Ag [Presence] in Specimen
31
181
1.73
2.17
1.2
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
164
0.36
2.16
1.8
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
62
2.27
2.08
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
96
2.00
2.06
1.7
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
96
2.00
2.06
1.7
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
96
2.00
2.06
1.7
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
23
125
1.86
2.03
2.7
2.3
mmol/l
105.0
105.2
0.12
23
125
(3041354) Potassium [Moles/volume] in Venous blood
23
125
1.86
2.03
2.7
2.3
mmol/l
3.9
4.1
0.67
23
125
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
932
9003
1.30
2.03
23.7
9.3
u/l
27.3
25.7
1.76
923
8607
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
485
4408
1.19
2.02
2.6
2.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
38
240
1.61
2.01
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
90
1176
0.74
1.96
4.0
5.0
%
33.2
32.7
0.14
60
768
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
39
2.58
1.92
2.2
2.4
u/ml
1026.8
1261.7
—
10
39
(3014765) Yersinia sp identified in Stool by Organism specific culture
38
243
1.58
1.92
1.3
1.1
—
—
—
0
0
(3013512) EKG study
306
2682
1.20
1.91
4.3
4.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
92
1.97
1.91
1.7
1.2
—
—
—
0
0
(1002224) Polysomnography panel
15
291
0.51
1.88
1.1
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
78
580
1.37
1.87
6.6
2.7
g/l
123.6
131.0
2.09
78
565
(42529406) Shigella sp [Presence] in Stool by Culture
38
245
1.57
1.86
1.3
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
93
1.95
1.85
1.7
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
17
3.54
1.84
1.2
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
12
4.18
1.82
2.6
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
41
271
1.53
1.81
2.7
3.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
47
322
1.48
1.77
1.0
1.1
—
180.5
—
0
11
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
371
0.58
1.74
1.5
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
36
2.51
1.74
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
24
2.93
1.72
4.4
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
13
3.86
1.71
6.6
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
73
546
1.36
1.71
1.1
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
55
2.20
1.67
1.2
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
13
62
2.11
1.66
3.3
3.6
%
68.1
52.6
—
7
41
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
25
2.81
1.65
2.1
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
83
1.94
1.65
3.4
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
64
472
1.38
1.64
4.2
3.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
56
2.16
1.61
2.3
2.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
77
1.96
1.59
3.1
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
109
1347
0.79
1.59
1.2
1.3
u/ml
23.0
13.5
0.41
46
498
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
90
705
1.30
1.56
3.4
2.2
ml/min/173m2
64.9
63.8
0.09
44
286
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
122
999
1.25
1.49
1.3
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
22
2.74
1.43
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
40
2.26
1.40
1.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
46
2.19
1.40
1.5
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
253
2844
0.85
1.39
4.0
3.8
%
22.1
23.8
1.25
127
1380
(3002619) Bacteria identified in Specimen by Culture
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
556
0.71
1.34
1.7
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
11
54
2.05
1.33
1.9
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
133
0.45
1.28
1.2
4.5
umol/l
323.7
352.6
—
6
118
(3025130) Human papilloma virus identified in Specimen
10
48
2.09
1.28
2.2
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
21
130
1.63
1.27
1.9
2.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
35
2.30
1.27
1.3
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
44
2.05
1.27
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
34
237
1.45
1.24
6.1
4.3
—
—
—
0
0
(3000012) Reticulocyte production index
9
45
2.01
1.23
1.1
1.7
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
11
56
1.97
1.22
1.1
1.1
mmol/l
2.1
2.0
0.05
11
51
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
17
101
1.69
1.20
3.1
4.2
—
—
—
0
0
(4015189)
0
34
0.00
1.16
0.0
2.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
18
110
1.65
1.16
1.4
1.3
mu/l
147.3
67.0
0.45
18
95
(4034850)
21
319
0.65
1.15
7.0
10.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
21
2.39
1.09
1.2
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
10
52
1.93
1.06
1.1
1.2
mmol/l
11.1
11.1
—
5
15
(3008037) Lactate [Moles/volume] in Venous blood
31
220
1.42
1.05
5.1
2.8
mmol/l
1.5
1.6
0.25
31
213
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
82
1.72
1.05
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
108
0.46
1.01
1.6
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
424
0.72
1.00
1.4
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
18
115
1.58
1.00
1.8
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
23
2.18
0.98
2.6
1.8
—
—
—
0
0
(4010399)
54
678
0.79
0.96
1.6
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
77
1.70
0.95
1.6
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
32
0.00
0.95
0.0
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
7
37
1.90
0.94
1.4
1.3
umol/l
11.2
4.0
—
7
15
(3038515) Glucose [Moles/volume] in Venous blood
29
210
1.39
0.91
5.4
2.9
mmol/l
6.8
7.7
1.66
29
203
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
351
1.29
0.88
1.4
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
42
1.91
0.88
1.0
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
42
1.91
0.88
1.0
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
98
835
1.19
0.88
2.0
1.8
%
1.5
1.5
0.05
80
708
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
64
1.73
0.86
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
13
80
1.63
0.84
1.3
1.4
—
32.6
—
0
5
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
47
1.71
0.80
1.5
2.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
62
511
1.23
0.79
2.3
2.2
nmol/l
12.7
14.8
1.40
57
447
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
173
1.40
0.79
1.7
1.8
iu/l
5.9
4.6
—
9
64
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
131
1.46
0.78
1.1
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
98
1.54
0.78
2.6
2.9
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
26
0.00
0.78
0.0
1.6
—
0.8
—
0
26
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
341
1.27
0.77
2.8
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
99
1.52
0.76
1.6
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
32
414
0.77
0.75
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
278
0.71
0.75
1.6
2.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
24
2.09
0.74
1.4
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
38
1.85
0.73
1.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
55
1.64
0.73
2.4
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
25
2.00
0.72
1.2
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
10
60
1.67
0.72
1.5
1.7
umol/l
17.8
14.0
—
10
54
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
68
1.62
0.72
1.1
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40
318
1.27
0.71
1.9
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
108
1225
0.87
0.70
12.6
6.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
27
1.86
0.68
1.4
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
59
1.53
0.68
5.2
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
59
1.53
0.68
1.6
1.5
g/l
1.0
0.9
—
9
59
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
59
1.53
0.68
5.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
59
1.53
0.68
5.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
70
596
1.19
0.67
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
67
569
1.19
0.66
4.4
2.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
23
171
1.35
0.66
1.9
1.7
—
—
—
0
0
(4024509)
12
78
1.54
0.65
1.7
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
44
1.59
0.65
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
79
1.52
0.62
1.5
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
71
1.56
0.62
23.2
1.8
%
10.9
10.7
0.05
11
71
(3051101) Glucose [Moles/volume] in Cord blood
0
21
0.00
0.60
0.0
6.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
177
1923
0.90
0.58
4.4
3.9
kg/l
1.0
1.0
0.80
26
280
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
35
1.72
0.57
1.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
241
0.74
0.57
1.8
1.7
e6/l
14042.2
11913.0
—
10
189
(3014051) Protein [Presence] in Urine by Test strip
26
203
1.29
0.56
2.0
2.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
44
367
1.21
0.55
1.7
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
30
372
0.80
0.54
1.4
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
82
1.47
0.54
1.8
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
62
535
1.17
0.54
2.9
3.3
e9/l
3.7
4.2
0.94
48
385
(3021788) Differential panel - Synovial fluid
23
178
1.30
0.53
1.7
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
39
1.54
0.53
1.0
1.1
—
11.4
—
0
7
(3016038) Potassium [Moles/volume] in Urine
10
66
1.52
0.52
2.1
1.2
mmol/l
31.3
35.7
—
10
58
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
804
8192
0.92
0.52
7.0
6.4
mmol/mol
40.3
40.6
0.36
761
7555
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
24
188
1.28
0.51
1.7
1.3
e6/l
47.3
825.8
0.77
19
158
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
24
188
1.28
0.51
1.5
1.2
e6/l
11.2
51.1
0.69
16
153
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
126
1380
0.90
0.50
1.2
1.3
iu/ml
50.9
36.8
0.27
42
429
(3008898) HLA-B27 [Presence]
17
224
0.75
0.50
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
41
344
1.20
0.49
1.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
217
2033
1.08
0.48
3.7
3.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
77
1.43
0.45
1.1
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
42
358
1.18
0.44
7.2
3.8
mmol/l
24.5
24.8
0.22
37
331
(4306422)
14
104
1.35
0.43
1.4
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
31
1.62
0.43
1.4
1.2
iu/ml
96.1
256.6
—
5
31
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
139
0.72
0.42
1.2
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
58
1.38
0.41
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
59
1.36
0.41
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
59
1.36
0.41
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
59
1.36
0.41
1.3
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
792
7787
1.07
0.40
5.4
4.6
mu/l
2.0
2.1
0.48
722
7024
(3045424) Erythrocytes [Presence] in Urine
16
123
1.31
0.40
1.4
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
18
0.00
0.40
0.0
1.3
—
9.2
—
0
7
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
102
0.68
0.39
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
61
1.31
0.39
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
61
1.31
0.39
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
61
1.31
0.39
1.3
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
11
80
1.38
0.38
4.3
1.8
u/field
1.8
1.6
—
5
31
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
36
1.39
0.38
3.4
3.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
89
1.35
0.38
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
268
0.82
0.37
2.5
2.4
ug/min
53.7
89.0
0.38
12
167
(4268621)
9
70
1.29
0.36
2.8
2.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
19
234
0.81
0.36
1.2
1.2
—
21.9
—
0
7
(3003740) Influenza virus B Ag [Presence] in Specimen
5
79
0.63
0.35
1.2
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
99
1.32
0.35
1.4
1.1
u/ml
3.4
7.6
—
8
48
(3002523) Influenza virus A Ag [Presence] in Specimen
5
80
0.62
0.35
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
122
0.74
0.35
1.1
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
122
0.74
0.35
1.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
122
0.74
0.35
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
124
0.72
0.35
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
124
0.72
0.35
1.2
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
707
6942
1.06
0.35
42.5
17.6
g/l
330.3
332.4
7.14
702
6887
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
44
1.37
0.34
2.0
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
166
0.78
0.33
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
155
1.23
0.32
1.1
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
98
0.71
0.31
1.3
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
53
1.32
0.31
2.4
2.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
341
3519
0.95
0.28
4.8
3.9
ug/l
2.2
2.0
0.57
297
3151
(3020682) Albumin/Creatinine [Ratio] in Urine
302
3125
0.95
0.28
3.8
4.0
mg/mmol
26.8
7.5
1.25
195
1988
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
103
1.27
0.28
1.5
1.1
u/ml
2.2
1.8
—
5
33
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
95
885
1.08
0.28
1.3
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
120
0.75
0.27
1.2
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
95
886
1.08
0.27
2.1
2.5
ug/l
5.3
8.1
1.70
84
779
(3044927) Protein electrophoresis panel - Urine
14
113
1.24
0.26
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
67
1.20
0.26
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
76
705
1.08
0.25
1.4
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
180
0.83
0.24
1.1
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
6
83
0.72
0.24
1.3
1.0
—
0.8
—
0
30
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
106
1.23
0.23
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
19
162
1.18
0.23
1.4
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
936
9297
1.06
0.22
48.1
19.4
e9/l
244.1
243.8
0.04
928
8996
(4211845)
5
41
1.22
0.22
3.4
3.2
—
—
—
0
0
(4027681)
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.4
—
7.2
—
0
5
(3019174) dRVVT (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
101
0.79
0.21
1.0
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
936
9300
1.06
0.21
47.9
19.4
fl
91.5
91.5
0.10
931
9114
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
460
1.09
0.21
1.2
1.2
iu/ml
140.0
146.9
0.05
13
186
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
936
9301
1.06
0.20
48.1
19.5
e9/l
6.5
6.7
2.09
927
8972
(3035941) MCH [Entitic mass]
936
9301
1.06
0.20
47.8
19.4
pg
30.2
30.5
3.75
931
9115
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
80
1.25
0.20
1.0
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
936
9302
1.05
0.20
48.1
19.5
e12/l
4.2
4.5
43.54
927
8968
(3027923) C peptide [Moles/volume] in Serum or Plasma
6
49
1.23
0.20
2.2
1.5
nmol/l
0.8
1.1
—
6
34
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
50
1.20
0.19
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
51
1.18
0.19
1.5
1.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
936
9304
1.05
0.19
48.4
19.6
g/l
126.0
136.3
66.86
930
9117
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
191
1971
0.96
0.17
2.8
2.8
ug/l
0.8
0.7
0.59
135
1369
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
82
1.22
0.17
1.0
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
67
0.75
0.17
1.0
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
194
0.87
0.16
3.2
3.4
mg/l
27.2
26.5
0.02
11
129
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
292
2854
1.03
0.16
2.7
2.2
u/l
342.9
234.7
0.52
277
2681
(21494755) Public health laboratory ask at order entry panel
47
504
0.93
0.16
1.2
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
6
79
0.76
0.15
1.0
2.0
ug/l
1.7
3.4
—
6
74
(3005322) IgE [Units/volume] in Serum or Plasma
50
470
1.07
0.14
1.2
1.2
u/ml
143.5
208.0
0.62
43
431
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
23
212
1.09
0.10
1.5
1.2
mg/l
569.7
505.7
0.28
23
197
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
48
1.04
0.09
2.0
2.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
20
184
1.09
0.09
1.3
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
20
184
1.09
0.09
1.4
1.2
mmol/l
3.8
3.9
0.28
20
168
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
54
1.11
0.09
1.3
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
44
420
1.05
0.08
7.4
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
185
0.92
0.08
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
6
71
0.84
0.07
1.0
1.0
—
1.0
—
0
23
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
72
0.83
0.07
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
25
266
0.94
0.07
1.4
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
78
1.03
0.07
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
78
1.03
0.07
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
128
1.10
0.06
1.4
1.5
%
73.8
60.8
—
5
85
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
201
0.94
0.04
2.4
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
23
241
0.95
0.04
1.4
1.6
iu/ml
0.1
0.1
—
5
54
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
19
180
1.06
0.04
1.1
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
293
2951
0.99
0.04
3.2
3.3
mg/l
1289.8
165.2
1.61
194
1886
(3037522) Nuclear Ab [Titer] in Serum
109
1075
1.02
0.03
1.3
1.3
titre
496.0
535.4
0.10
20
252
(4146454)
13
122
1.07
0.02
2.2
2.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
158
0.95
0.02
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
86
868
0.99
0.01
1.6
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
305
3041
1.00
0.01
3.2
3.2
mmol/l
7.3
7.5
0.32
253
2557
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
124
1.05
0.00
1.0
1.2
—
—
—
0
0
(4094501)
26
254
1.02
0.00
1.1
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
11
114
0.96
0.00
2.4
2.7
mg/l
18.6
20.0
—
5
27
(3023419) Bacteria identified in Sputum by Culture
12
116
1.03
0.00
1.6
2.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
27
272
0.99
0.00
1.4
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
121
0.99
0.00
1.1
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
15
153
0.98
0.00
1.1
1.9
pmol/l
180.9
217.4
1.09
15
142
(40761535) Cells panel - Urine sediment
77
767
1.00
0.00
3.7
3.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
155
0.97
0.00
1.6
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.8
—
2.2
—
0
6
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
99.5
—
0
6
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
86
0.93
0.00
1.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
5
56
0.89
0.00
1.6
1.5
—
73.2
—
0
5
(44806071)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
16.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
10.3
—
0
7
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
83
0.96
0.00
1.1
1.7
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
32
320
1.00
0.00
1.2
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_SMALL_INTESTINE_EXALLC – Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)
GWS hits: 4
This endpoint is excluded (different definition than used in FinnGen).